Description: Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.
Home Page: www.granulesindia.com
My Home Hub
Hyderabad,
500081
India
Phone:
91 40 6904 3500
Officers
| Name | Title |
|---|---|
| Dr. Krishna Prasad Chigurupati B.Sc. | Chairman & MD |
| Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D. | Joint MD, CEO & Additional Director |
| Mr. Harsha Chigurupati BBA | Executive Director |
| Mr. Sanjay Kumar | President and Chief Strategy & Sustainability Officer |
| Mr. Mukesh Surana | Chief Financial Officer |
| Mr. Sethu Madhavan Sankaran | Senior Vice President of API Manufacturing & Operations |
| Dr. P. V. Srinivas | Chief Technology Officer |
| Ms. Chaitanya Tummala | Company Secretary & Compliance Officer |
| Mr. Atul Dhavle B.E. | Chief Human Resources Officer |
| Ms. Priyanka Chigurupati | Whole-Time Director |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 15.4083 |
|---|---|
| Trailing PE: | 28.6536 |
| Price-to-Book MRQ: | 4.0709 |
| Price-to-Sales TTM: | 3.1093 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 4057 |